Spinal muscular atrophy
Also known as: SMA, 5q spinal muscular atrophy, SMN1-related spinal muscular atrophy, Autosomal recessive proximal spinal muscular atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder characterised by deficiency of the survival motor neuron (SMN) protein. This deficiency precipitates motor neuron degeneration, culminating in progressive muscular atrophy and paresis. Given the systemic impact on ventilation, deglutition, and spinal morphology, management must be coordinated by a specialist multidisciplinary team. Early diagnosis and the administration of disease-modifying therapies—including nusinersen, risdiplam, or onasemnogene abeparvovec—are critical for improving clinical trajectories. Traditional Chinese Medicine (TCM) provides a framework for addressing secondary constitutional symptoms, such as anorexia or sleep disturbances, but cannot modify the genetic pathology or substitute for standard medical and rehabilitative care. Cited evidence, including consensus statements and case reports, indicates no clinical evidence that acupuncture or herbal medicine can treat SMA. Supportive TCM interventions necessitate rigorous risk assessment and stringent coordination with the neuromuscular specialist team.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain adherence to specialist neuromuscular follow-up and prescribed disease-modifying, respiratory, and nutritional care; do not delay treatment for adjunctive consultations.
- •Adhere to the individualised rehabilitation programme; ensure adequate rest and avoid exhaustive exertion or forced passive stretching.
- •Utilise prescribed seating, orthoses, and pressure-relief routines; promptly report skin breakdown or reduced sitting tolerance.
- •Maintain a systematic record of appetite, body mass, deglutition, sleep, and everyday function, sharing changes with the multidisciplinary team.
Cautions & Contraindications
- •Do not substitute acupuncture or herbs for prompt SMA diagnosis, presymptomatic treatment or ongoing disease-modifying therapy. The consensus supports early intervention and multidisciplinary management, not TCM efficacy.[]
- •Severe kyphoscoliosis, respiratory compromise or spinal instrumentation requires individual clearance and modified positioning; avoid deep thoracic or paraspinal needling where anatomy is distorted. This is a procedural precaution informed by the complications described, not a tested recommendation from the case report.[]
- •Defer elective adjunctive treatment during unexplained rapid functional decline and arrange neurological reassessment. The adult case illustrates diagnostic complexity rather than establishing the safety of adjunctive treatment.[]
- •Do not assume herbs are compatible with gene therapy, nusinersen or risdiplam. Obtain prescriber or pharmacist review, especially around treatment monitoring or procedures; the supplied consensus abstract does not establish herb–medicine interaction safety.[]
When to reassess or seek care again
Before any adjunctive trial, agree on one or two symptom goals and record a baseline, such as pain score, sleep disruption or sitting comfort. Review tolerability after every session and overall benefit within 2–4 weeks. Stop if there is no meaningful symptom improvement or if fatigue, pain or function worsens. Neuromuscular clinicians should track motor function using age-appropriate validated measures; changes must not be attributed to adjunctive care without evidence. New respiratory, swallowing or motor deterioration triggers immediate medical review rather than waiting for the scheduled reassessment.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Journal of the Formosan Medical Association = Taiwan yi zhi · 2026
- Journal of medical case reports · 2026
- BMC neurology · 2026
- Frontiers in medicine · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
